What is NDC 73190-098?

73190-098 is the product NDC for Atovaquone, Atovaquone 750 mg/5mL suspension, listed with the FDA by AvKARE. It has 1 package NDC, shown above in 10- and 11-digit form.

AvKARE, NDC labeler code 73190. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Atovaquone?

20 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Atovaquone NDC 73190-098 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)73190-098Labeler and product segments. Claims need a package NDC.

Product NDC at billing width73190-0098Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
73190-098-21	73190009821	1 BOTTLE in 1 CARTON (73190-098-21) / 210 mL in 1 BOTTLEMarketed from Jun 14, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Atovaquone
Generic name (nonproprietary): atovaquone
Active ingredients: Atovaquone — 750 mg/5mL
Dosage form: Suspension
Route: Oral
Labeler: AvKARENDC labeler code 73190
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 202960
Marketing start: Jun 14, 2026
Listing expires: Dec 31, 2027
Identifiers: Product ID 73190-098_54423fee-da61-25dc-e063-6294a90a2552SPL ID 54423fee-da61-25dc-e063-6294a90a2552SPL set ID 54423fee-da60-25dc-e063-6294a90a2552RxCUI 308429UNII Y883P1Z2LT
Pharmacologic class: Antimalarial; Antiprotozoal

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N473190009821 followed by a unit qualifier and the quantity

Package 73190-0098-21. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 14, 2026.

Indications (excerpt from the label)

Atovaquone oral suspension is a quinone antimicrobial drug indicated for: Prevention of Pneumocystis jirovecii pneumonia (PCP) in adults and adolescents aged 13 years and older who cannot tolerate trimethoprim-sulfamethoxazole (TMP-SMX). (1.1) Treatment of mild-to-moderate PCP in adults and adolescents aged 13 years and older who cannot tolerate TMP-SMX. (1.2) Limitations of Use (1.3) : Treatment of severe PCP (alveolar arterial oxygen diffusion gradient [(A-a)DO 2 ] >45 mm Hg) with atovaquone oral suspension has not been studied. The efficacy of atovaquone oral suspension in subjects who are failing therapy with TMP-SMX has also not been studied. 1.1 Prevention of Pneumocystis jirovecii Pne…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 73190-098

What is NDC 73190-098?: 73190-098 is the product NDC for Atovaquone, Atovaquone 750 mg/5mL suspension, listed with the FDA by AvKARE. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Atovaquone.
What is the active ingredient?: Atovaquone.
Who is the labeler?: AvKARE, NDC labeler code 73190. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Atovaquone?: 20 other product NDCs are listed under this name. See all Atovaquone NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Atovaquone NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Atovaquone	Atovaquone 750 mg/5mL	SuspensionOral	AvPAK	50268-119	50268-0119-12
Atovaquone	Atovaquone 750 mg/5mL	SuspensionOral	PAI Holdings, LLC dba PAI Pharma	0121-0956	00121-0956-08
Atovaquone	Atovaquone 750 mg/5mL	SuspensionOral	A2A Integrated Pharmaceuticals, LLC	73141-104	73141-0104-42
Atovaquoneatovaquone oral suspension	Atovaquone 750 mg/5mL	SuspensionOral	Major Pharmaceuticals	0904-7459	00904-7459-2500904-7459-53
Atovaquone	Atovaquone 750 mg/5mL	SuspensionOral	Kesin Pharma	81033-104	81033-0104-2281033-0104-4281033-0104-50
Atovaquone	Atovaquone 750 mg/5mL	SuspensionOral	NorthStar RxLLC	72603-248	72603-0248-01
Atovaquone	Atovaquone 750 mg/5mL	SuspensionOral	PAI Holdings, LLC dba PAI Pharma	0121-1016	00121-1016-1800121-1016-42
Atovaquone	Atovaquone 750 mg/5mL	SuspensionOral	Abon Pharmaceuticals, LLC	42239-001	42239-0001-0842239-0001-66
Atovaquone	Atovaquone 750 mg/5mL	SuspensionOral	Lupin Pharmaceuticals, Inc.	70748-299	70748-0299-01
Atovaquone	Atovaquone 750 mg/5mL	SuspensionOral	Bionpharma Inc.	69452-252	69452-0252-87

All 21 Atovaquone NDCs

Other NDCs under ANDA 202960

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 202960
Product	Strength	Form · route	Labeler	Product NDC
Atovaquone	Atovaquone 750 mg/5mL	SuspensionOral	Amneal Pharmaceuticals LLC	65162-693
Atovaquone	Atovaquone 750 mg/5mL	SuspensionOral	AvPAK	50268-119